<DOC>
	<DOCNO>NCT03057379</DOCNO>
	<brief_summary>The overarch goal study evaluate effectiveness , cost-effectiveness sustainability utilize statewide Immunization Information Systems ( IIS ) conduct centralize reminder/recall ( R/R ) improve Human Papiloma Virus ( HPV ) vaccination rate among adolescent age 11-17 .</brief_summary>
	<brief_title>HPV IIS Reminder/Recall- New York State</brief_title>
	<detailed_description>The overarch goal study evaluate effectiveness , cost-effectiveness sustainability utilize statewide Immunization Information Systems ( IIS ) conduct centralize reminder/recall ( R/R ) improve HPV vaccination rate among adolescent age 11-17 . The investigator extend previous research effectiveness centralize R/R new population -- adolescent due HPV vaccine -- test use centralize R/R cancer-prevention strategy . Investigators assess effect centralize R/R two state -- one one without mandate reporting vaccination IISs , disseminate IIS R/R state . Investigators implement , evaluate ( use RE-AIM framework 31-36 ) , disseminate collaborative , IIS-based centralized HPV vaccine R/R model partnership public health system primary care practice two state ( NY , CO ) collaborate remind parent HPV vaccination . Specific Aims hypothesis : Aim # 1 : Adapt IIS message delivery system ( e.g. , algorithms ) previously develop centralize R/R vaccine fit HPV vaccine IIS R/R . Aim # 2 : Assess impact cost-effectiveness centralize IIS-based ( IIS-C ) autodialer ( phone ) R/R increase vaccine rate [ initial dose ( HPV # 1 ) complete series ( HPV # 3 ) ] among teen . Conduct pragmatic trial , assess impact cost effectiveness centralize IIS-based ( IIS-C ) autodialer ( phone ) R/R increase initiation completion rate HPV vaccine series adolescent age 11-17 year . The investigator use within-practice design , randomize patient within randomly select primary care practice IIS-C R/R ( 1 , 2 , 3 reminder per dose ) compare usual care ( 0 reminder study ) . The investigator apply RE-AIM framework evaluate reach , effectiveness/cost effectiveness , adoption , implementation IIS-C R/R . Hypothesis 2a : IIS-C R/R result high HPV vaccination rate usual care . Hypothesis 2b : IIS-C R/R result high HPV vaccination rate usual care key subgroup ( male female , young old teen , urban//rural teen ) . Hypothesis 2c : IIS-C R/R cost-effective ( cost/vaccine receive ) usual care . Aim # 3 : Disseminate IIS-C R/R across NY CO pilot four IISs : ( ) Develop IIS-C HPV R/R toolkit , ( b ) Use technical advisory group , ( c ) Initiate IIS-C R/R four IISs [ Yr. 4 ] . By end study investigator feasible , sustainable , cost-effective model HPV vaccine reminder use nationally prevent cervical cancer HPV-related cancer .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>11 17 year age patient participate practice ( practice randomly select ) either due HPV dose baseline , initiate yet complete HPV series baseline complete HPV vaccination series</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HPV vaccine</keyword>
	<keyword>Immunization registry</keyword>
	<keyword>Reminder recall</keyword>
</DOC>